← Leaderboards
Luis E Quadri
Weill Medical College Of Cornell Univ
$5,393,602
Attributed
$7,079,427
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $823.7K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,079,427 · 7
By mechanism
R01$5,888,850 · 3
R21$445,888 · 1
R15$430,689 · 1
R03$314,000 · 2
Top collaborators
- Derek S Tan5 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Carl F Nathan$43,444,016
- Kyu Y Rhee$16,751,305
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisMulti-Drug ResistanceTuberculosis DrugsBaseVirulenceTuberculosisResistanceLeadGrowthBacteriaAnabolismPharmaceutical PreparationsMycobacterialProductionEnzymesIn VitroMacrophageProteinsPathogenAntibioticsInhibitor/AntagonistReadinessMouse ModelCollege
Grant awards (20)
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis$666,740
R01 · FY2020 · AI
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis$666,740
R01 · FY2019 · AI
Gene Essentiality in Mycobacterium kansasii$78,500
R03 · FY2019 · AI · contact PI
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis$666,740
R01 · FY2018 · AI
Gene Essentiality in Mycobacterium kansasii$78,500
R03 · FY2018 · AI · contact PI
Interrogation of Mycobacterium kansasii with Forward Genetics$78,500
R03 · FY2018 · AI · contact PI
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis$666,740
R01 · FY2017 · AI
Interrogation of Mycobacterium kansasii with Forward Genetics$78,500
R03 · FY2017 · AI · contact PI
Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis$704,690
R01 · FY2016 · AI
BIOSYNTHESIS OF MYCOBACTERIAL DIMYCOCEROSATE ESTER VIRULENCE FACTORS$430,689
R15 · FY2014 · AI · contact PI
Mycobacterial Siderophores: Assembly, Assembly Inhibition, and Role in Virulence$417,719
R01 · FY2010 · AI · contact PI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition$333,124
R01 · FY2010 · AI · contact PI
Mycobacterial Siderophores: Assembly, Assembly Inhibition, and Role in Virulence$344,724
R01 · FY2009 · AI · contact PI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition$313,427
R01 · FY2009 · AI · contact PI
Mycobacterial Siderophores: Assembly, Assembly Inhibition, and Role in Virulence$110,310
R01 · FY2009 · AI · contact PI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition$313,427
R01 · FY2008 · AI · contact PI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition$316,669
R01 · FY2007 · AI · contact PI
Mycobacterial PDIM/PGL: synthesis pathway and inhibition$367,800
R01 · FY2006 · AI · contact PI
Virulence-conferring siderophore biosynthesis inhibitors$235,888
R21 · FY2006 · AI · contact PI
Virulence-conferring siderophore biosynthesis inhibitors$210,000
R21 · FY2005 · AI